Stock Research for NURO


Featured Broker: Ally Invest

Get the due diligence for another stock.


NURO Stock Chart & Research Data

The NURO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NURO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


NURO Due diligence Resources & Stock Charts

The NURO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View NURO Detailed Price Forecast - CNN Money CNN View NURO Detailed Summary - Google Finance
Yahoo View NURO Detailed Summary - Yahoo! Finance Zacks View NURO Stock Research & Analysis -

Stock Analysis

TradeIdeas View NURO Trends & Analysis - Trade-Ideas Barrons View NURO Major Holders - Barrons
NASDAQ View NURO Call Transcripts - NASDAQ Seeking View NURO Breaking News & Analysis - Seeking Alpha
Spotlight View NURO Annual Report - OTC Report View NURO OTC Short Report -
TradeKing View NURO Fundamentals - TradeKing Charts View NURO SEC Filings - Bar Chart
WSJ View Historical Prices for NURO - The WSJ Morningstar View Performance/Total Return for NURO - Morningstar
MarketWatch View the Analyst Estimates for NURO - MarketWatch CNBC View the Earnings History for NURO - CNBC
StockMarketWatch View the NURO Earnings - StockMarketWatch MacroAxis View NURO Buy or Sell Recommendations - MacroAxis
Bullish View the NURO Bullish Patterns - American Bulls Short Pains View NURO Short Pain Metrics -

Social Media Mentions

StockTwits View NURO Stock Mentions - StockTwits PennyStocks View NURO Stock Mentions - PennyStockTweets
Twitter View NURO Stock Mentions - Twitter Invest Hub View NURO Investment Forum News - Investor Hub
Yahoo View NURO Stock Mentions - Yahoo! Message Board Seeking Alpha View NURO Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for NURO - Insider Cow View Insider Transactions for NURO - Insider Cow
CNBC View NURO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for NURO - OTC Markets
Yahoo View Insider Transactions for NURO - Yahoo! Finance NASDAQ View Institutional Holdings for NURO - NASDAQ

Stock Charts

FinViz View NURO Stock Insight & Charts - StockCharts View NURO Investment Charts -
BarChart View NURO Stock Overview & Charts - BarChart Trading View View NURO User Generated Charts - Trading View

Latest Financial News for NURO

Free Technical Snapshots for Ekso Bionics and Three More Medical Supplies Stocks
Posted on Friday May 11, 2018

LONDON, UK / ACCESSWIRE / May 11, 2018/ If you want a free Stock Review on EKSO sign up now at has initiated research coverage on Ekso Bionics Holdings Inc. (NASDAQ: EKSO), Haemonetics Corp. (NYSE: HAE), Hill-Rom Holdings Inc. (NYSE: HRC), and NeuroMetrix Inc. (NASDAQ: NURO). Companies in the Medical Instruments and Supplies Manufacturing industry primarily research, develop, and produce nonelectronic medical, surgical, dental, and veterinary instruments and apparatus, such as syringes, anesthesia apparatus, blood transfusion equipment, catheters, surgical clamps, and medical thermometers.

Preliminary Results from Quell Chronic Low Back Pain Study to be Presented at World Institute of Pain World Congress
Posted on Thursday May 03, 2018

NeuroMetrix, Inc. (NURO), today reported that preliminary results from a study of Quell® wearable pain relief in chronic low back pain will be presented at the 9th World Congress of the World Institute of Pain in Dublin, Ireland May 9-12, 2018. Subjects in the experimental group exhibited reduced pain interference with function and pain catastrophizing compared to the control group. Subjects in the experimental group with greater sensitivity on quantitative sensory testing had more disability and higher Quell use, but sensitivity did not predict pain outcomes.

NeuroMetrix, Inc. to Participate in Upcoming Disruptive Growth & Healthcare Conference in New York City
Posted on Tuesday May 01, 2018

WALTHAM, Mass., May 01, 2018-- NeuroMetrix, Inc., announced today that it will be participating in the 3rd annual Disruptive Growth & Healthcare Conference in New York City on May 8-9, 2018 sponsored by ...

NeuroMetrix to Present Quell Data at Upcoming American Academy of Pain Medicine Annual Meeting
Posted on Tuesday April 24, 2018

WALTHAM, Mass., April 24, 2018-- NeuroMetrix, Inc. today reported that it will present two scientific posters at the upcoming 2018 American Academy of Pain Medicine Annual Meeting to be held in Vancouver, ...

Enter a stock symbol to view the stock details.